| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/19/2001 | WO2000074707A3 Use of interleukin-11 to treat hemorrhagic shock |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | WO2000045894A3 Use of pyrazole carboxamides |
| 04/19/2001 | WO2000029623A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 04/19/2001 | WO2000026245A3 Human membrane transport proteins |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | CA2392209A1 M-substituted benzoic acid derivatives having integrin .alpha.v.beta.3 antagonistic activity |
| 04/19/2001 | CA2388962A1 A molecular framework for amino acids or heterologous amino acid sequences |
| 04/19/2001 | CA2388813A1 Heterocyclic sodium/proton exchange inhibitors and method |
| 04/19/2001 | CA2387545A1 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1) |
| 04/19/2001 | CA2387484A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | CA2387314A1 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/19/2001 | CA2386848A1 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
| 04/19/2001 | CA2386821A1 3-aminopiperidine derivatives as integrin .alpha.v.beta.3 antagonists |
| 04/19/2001 | CA2385179A1 Isoagglutinin-depleted blood compositions and methods of making same |
| 04/19/2001 | CA2382605A1 Pyrimidine derivatives |
| 04/18/2001 | EP1092716A2 Derivatives of benzothiophenes, benzofurans and indoles, method for their preparation and pharmaceutical compositions containing them |
| 04/18/2001 | EP1092029A1 A novel human thrombopoietin mutein |
| 04/18/2001 | EP1091955A1 Quinolones as serine protease inhibitors |
| 04/18/2001 | EP1091930A1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/18/2001 | CN1291892A Substituted oxoazaheterocyclyl factor Xa inhibitors |
| 04/18/2001 | CN1291890A 20-Hete antagonists and agonists |
| 04/18/2001 | CN1291488A Ningxueling capsule |
| 04/17/2001 | US6218513 Genetically engineered hemoglobins; for used to treat anemia and hemorrhages; for amplification of cells oxygen carrying capabilities |
| 04/17/2001 | US6218412 Therapy and prophylaxis of diseases where an increased concentration of interleukin-1.beta. participates in their course, for example septic shock, leukemia, hepatitis, muscular degeneration, degenerative joint diseases |
| 04/17/2001 | US6218403 Antithrombotic and antiatherogenic pharmaceutical composition including a thienopyridine derivative and an HMG-CoA-reductase inhibitor |
| 04/17/2001 | US6218389 For therapy and prophylaxis of arthritis, cancer, cardiovascular disorders; skin disorders; ocular disorders; inflammation and gum diseases, multiple sclerosis, cachexia, preventing loosening of prosthetic devices |
| 04/17/2001 | US6218382 For prophylaxis or therapy of thrombosis |
| 04/17/2001 | US6218370 Useful for cell transfection |
| 04/17/2001 | US6218365 Serine protease inhibitors |
| 04/17/2001 | US6218148 DNS encoding stem cell factor |
| 04/17/2001 | US6217859 Orally administering genetic engineered bacteria |
| 04/17/2001 | CA2064473C Chimeric amino acids and peptides containing these analogues |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025445A1 Fibrinolytically active polypeptide |
| 04/12/2001 | WO2001025437A2 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | WO2001025436A2 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | WO2001025422A2 Antisense compositions and cancer-treatment methods |
| 04/12/2001 | WO2001025398A2 Process for inducing functional tolerance to gene transfer products |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025257A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024823A1 Cd40 antagonist for treating psoriasis |
| 04/12/2001 | WO2001024817A2 Pharmaceutical compositions of fibrinolytic agent |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024793A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024626A1 Prevention and treatment of diseases associated with blood coagulation |
| 04/12/2001 | WO2000061755A3 Secreted human proteins |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | WO2000026667A9 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 04/12/2001 | WO2000004891A3 Anti-ulcer composition |
| 04/12/2001 | DE19943634A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2388408A1 Prevention and treatment of diseases associated with blood coagulation |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386461A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same |
| 04/12/2001 | CA2386185A1 Fibrinolytically active polypeptide |
| 04/12/2001 | CA2385966A1 Pharmaceutical compositions of fibrinolytic agent |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385220A1 Antisense compositions and cancer-treatment methods |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/11/2001 | EP1090130A1 Protein c derivatives |
| 04/11/2001 | EP1090128A1 Modified vitamin-k-dependent polypeptides |
| 04/11/2001 | EP1090003A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1089872A1 Multi-action particle for structuring biological media |
| 04/11/2001 | EP1089762A1 Konjugat |
| 04/11/2001 | EP1089723A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 04/11/2001 | EP0710285B1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 04/11/2001 | CN1291193A Novel triazolo (4.5-d) pyrimidine compounds |
| 04/11/2001 | CN1291192A 5,6,7-trino-4,8-inter-m-phenylene PGI2 derivative and drugs containing the same |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1064257C External use hemostatic powder |
| 04/11/2001 | CN1064236C Application of pyromeconic acid and heteroside (eigeron glucoside) in pharmacy |
| 04/11/2001 | CN1064234C Application of di-caffee acyl-oxy-quininic acid in pharmacy |
| 04/10/2001 | US6214992 Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation |
| 04/10/2001 | US6214856 Treating neurodegenerative disorders, e.g., alzheimer's disease, strokes, traumatic brain injury; antiischemic agents; muscular dystrophy; also cataracts; platelet aggregation |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214841 Anticoagulants |
| 04/10/2001 | US6214817 Nitrogen macrocycle complexes with manganese and iron |
| 04/10/2001 | US6214808 Hemostatic agent |
| 04/10/2001 | US6214807 Images and cardiovascular disorders |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214333 Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
| 04/10/2001 | CA2140543C Thrombin receptor antagonists |
| 04/10/2001 | CA2046861C K2p pro stabilisation |
| 04/05/2001 | WO2001023598A1 41 human secreted proteins |
| 04/05/2001 | WO2001023554A1 The prv-1 gene and use thereof |